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Impact and Implications 
- Psychological interventions offer a potential way to improve outcomes in MDs, which 
are progressive and mostly without disease modifying treatment. Yet, a dearth of a 
research using longitudinal designs means that we are unsure which psychological 
variables represent viable treatment targets in this context.  
- In line with the theoretical assumptions implicit in Acceptance and Commitment 
Therapy (ACT), this study suggests that psychological flexibility is a distinct process, 
which influences life satisfaction and anxiety in muscle disorders. 
- This provides evidence that ACT may have utility in the context of MDs. However, 
trials of ACT are now required to establish whether manipulation of psychological 
flexibility improves outcomes in muscle disorders. 
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Abstract 
Purpose/Objective: Acceptance and Commitment Therapy (ACT), a newer type of behavior 
therapy which targets psychological flexibility, may have particular utility in the context of 
muscle disorders. However, there has been no formal investigation of psychological 
flexibility in this population. This longitudinal observational study investigated whether 
psychological flexibility is cross-sectionally related to, and prospectively influential on, life 
satisfaction and mood in muscle disorders.  
Research Method/Design: Data were collected via online questionnaire batteries, completed 
at baseline then repeated four months later. Cross-sectional and prospective regression 
analyses examined relationships between validated measures of disability level, 
psychological flexibility (experiential avoidance, cognitive fusion and valued living) and 
illness perceptions (a psychological variable with known influence in muscle disorders), and 
outcomes (life satisfaction, anxiety and depression).  
Results: A sample of 137 people with a range of muscle disorders participated. In cross-
sectional analyses, psychological flexibility explained significant unique variance in addition 
to illness perceptions (ΔR2 = 0.17-0.34, p = <.001). In prospective analyses, psychological 
flexibility alone was predictive of change in life satisfaction (ΔR2 = 0.04, p = .01) and anxiety 
(ΔR2 = 0.03 p = .04) over four months. No independent variables were predictive of change in 
depression over four months, and disability level had no significant influence on outcomes.  
Conclusions: Psychological flexibility influences important outcomes in muscle disorders. 
Experimental studies are required to establish if increased psychological flexibility leads to 
improved outcomes. 
 
Key words: muscle disorders; muscular dystrophy; Acceptance and Commitment Therapy; 
illness perceptions; psychological flexibility 
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The influence of psychological flexibility on life satisfaction and mood in muscle 
disorders 
 
Muscle disorders (MDs) are a group of genetic and acquired neuromuscular 
conditions the majority of which are progressive. Specific diagnoses include limb-girdle 
muscular dystrophy, facioscapulohumeral muscular dystrophy and inclusion body myositis. 
They principally affect muscle tissue, causing an insidious decline in physical functioning 
and mobility. Muscle weakness may also cause dysarthria, dysphagia, and opthalmopariesis; 
while cardiac and respiratory symptoms, and pain and fatigue are often reported (Della Marca 
et al., 2013; Merrison & Hanna, 2009). MDs are associated with reduced quality of life and 
increased depression and anxiety (Bungener, Jouvent, & Delaporte, 1998; Burns, Graham, 
Rose, & Simmons, 2012; Graham, Rose, Grunfeld, Kyle, & Weinman, 2011). 
Disease modifying treatments are unavailable for most MDs and there are no cures. 
Most interventions manage symptomatic complications to maintain quality of life, for 
example: physiotherapy and orthoses to maximise physical functioning, or medication for 
pain and fatigue (Merrison & Hanna, 2009). As evidenced in other chronic diseases (Astin, 
Beckner, Soeken, Hochberg, & Berman, 2002; Safren et al., 2014), psychological 
interventions may offer another way to improve outcomes in MDs (Graham, Simmons, 
Stuart, & Rose, 2015). Yet, to date, there has been just one such trial with an MD group –
specifically aimed at reducing fatigue (Voet et al., 2014). There have been no trials of 
psychological interventions for improving quality of life/life satisfaction and mood in MD.  
Psychological Flexibility  
Of potentially applicable psychological interventions, Acceptance and Commitment 
Therapy (ACT) may be particularly suited to improving quality of life/life satisfaction and 
mood in MDs (Graham, Simmons, Stuart, & Rose, 2015). ACT is a “third wave” behavior 
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therapy which specifically aims to increase  psychological flexibility (PF) (Hayes, Luoma, 
Bond, Masuda, & Lillis, 2006), defined as: being present in the here-and-now (present-
moment focus), flexibly pursuing behaviours which are in line with deeply held values 
(valued-living), in acceptance of difficult thoughts and feelings, such as worries or fears 
(experiential acceptance); within this, being able to see thoughts as transient mental events 
(cognitive defusion) that are separate from the person who is doing the thinking (self-as-
context) (Bond, Hayes, & Barnes-Holmes, 2006). 
There are practical and theoretical reasons why ACT may be useful in MDs. 
Practically, given that MDs are progressive, exact significant functional impairment, and are 
without treatment, negative beliefs (about illness, self and future) are to be expected at times, 
and distress - although this can become problematic - may be a natural response to these 
challenges. Thus, ACT (i.e. increasing PF) may offer clinicians greater scope to improve 
outcomes than teaching participants to change negative beliefs or to control distress. On a 
theoretical level, PF is conceptualized to explain individuals’ differential ability to undertake 
meaningful activity in the face of difficult circumstances – such as the challenges implicit in 
living with MDs and associated physical (pain, fatigue) and emotional (anxiety, fear, sadness) 
discomfort. Indeed, PF is predictive of meaningful outcomes in chronic pain (McCracken & 
Vowles, 2014), and other neuromuscular disease (Pakenham & Fleming, 2011). However, at 
present, we have only indirect evidence that PF is influential in MDs. This is mostly derived 
from the aforementioned studies with other chronic diseases, alongside one cross-sectional 
study with a small sub-sample of people with MDs, which showed that a willingness to 
experience pain, when this facilitated valued-activity, was negatively associated with 
depression (Kratz, Hirsh, Ehde, & Jensen, 2013). 
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The Present Study 
We investigated the role of PF in explaining life satisfaction and mood in MDs. Since 
it is feasible that some aspects of PF may be more influential than others (Graham et al., 
2014), we recorded key individual facets of psychological flexibility, which can be measured 
with existing questionnaires: experiential avoidance, valued-living, cognitive fusion. We also 
aimed to establish if PF explains unique variance in outcomes in addition to variables with 
known explanatory value in MDs. Thus, illness perceptions were included in the analysis; 
these are beliefs about the time-course of the health threat, its consequences and if it can be 
cured or controlled, amongst a range of other beliefs (Petrie & Weinman, 2012). Cross-
sectional studies demonstrate that they explain between 5% and 37% of the variance in 
quality of life, and 25% of the variance in mood in this context (Graham et al., 2014; Rose et 
al., 2012; Sadjadi, Rose, & Group, 2010).  
Therefore, we investigated the cross-sectional and prospective influence of PF 
(experiential avoidance, cognitive fusion and valued living) on life satisfaction and mood 
over the effects of disability level, and illness perceptions. We expected that PF would 
explain additional variance in life satisfaction and mood in both cross-sectional and 
prospective analyses.  
Methods 
Participants and Procedure 
Participants were recruited via a news story on the Muscular Dystrophy Campaign 
(United Kingdom) website. A link directed participants to online information sheets, consent 
forms and the first questionnaire battery. Participants assessed themselves against 
inclusion/exclusion criteria. They were eligible if they had a diagnosis of MD with duration 
of greater than six months and were aged 18-75 years. They were ineligible if: they had major 
active co-morbidities unrelated to MD (such as stroke); experienced cognitive impairment or 
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myotonic dystrophy (which is associated with cognitive impairment [Minnerop et al., 2011]); 
were unable to read English; had major diagnosed active mental health co-morbidities, for 
example psychosis or major depressive disorder; or, were participating in treatment 
intervention studies. To help ensure that only the desired population participated: we 
recruited from a MD specific website, participants typed their exact diagnosis, and we kept 
secondary gain low – there were no rewards for participation. As an additional quality 
assurance step, only those who completed all questionnaires were included in the analyses. 
The questionnaire battery contained measures of dependent and independent variables 
(listed below) and recorded demographics (MD diagnosis, age, gender, and years since they 
first noticed symptoms). Four months later, participants were e-mailed a link to the second 
questionnaire battery. This again recorded the dependent variables but omitted the 
independent variables, except disability level and illness perceptions (illness perceptions data 
collected at time 2 are not presented). Favorable ethical opinion was given by Department of 
Health in Social Sciences ethics committee at the University of Edinburgh.  
Measures  
Dependent variables. 
The Satisfaction With Living Scale (SWLS) (Diener, Emmons, Larsen, & Griffin, 
1985) is a five-item uni-dimensional measure of life satisfaction. Scores range from 0-35; 
higher scores indicate greater life satisfaction. Internal consistency in the present study was 
very good (α = .88).  
The Generalised Anxiety Disorder 7-item Scale (GAD-7) (Spitzer, Kroenke, 
Williams, & Lowe, 2006) is a seven-item measure of anxiety. Scores can range from 0-21, 
with higher scores indicating more severe anxiety. The cut-off indicating the possible 
presence of an anxiety disorder is a score of above 10 (Williams, 2014). Internal consistency 
in the present study was excellent (α = .90). 
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The 9-item version of the Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer, 
& Williams, 2001) is a nine-item measure of depression. Scores can range from 0-27, with 
higher scores indicating more severe depression. The cut-off indicating the possible presence 
of major depressive disorder is between 8 and 11 (Manea, Gilbody, & McMillan, 2012). In 
the present study the internal consistency of the PHQ-9 was very good (α = .86).  
Independent variables. 
The Stanford Health Assessment Questionnaire – Disability Index (HAQ-DI) 
(Fries, Spitz, & Young, 1982) a is a measure of impairment in physical functioning, or 
disability level, based on eight domains (dressing, arising, eating, walking, hygiene, reach, 
grip, and activities). There are various ways to score the HAQ-DI. As in previous studies with 
MD populations (Graham et al., 2014; Rose et al., 2012), to ensure that we assessed disability 
(as opposed to adaptation), we used the alternative scoring method which does not consider 
the use of mobility aides and averages the domains to give a total score (range 0 – 3) (Bruce 
& Fries, 2003). Higher scores indicate greater functional impairment. The internal 
consistency of the sub-scales ranged from α = .71 to α = .89. 
The Brief Illness Perception Questionnaire (Brief IPQ) (Broadbent, Petrie, Main, & 
Weinman, 2006) was used to capture illness perceptions. Eight of nine possible domains were 
utilized (Cause domain excluded). Scores on each domain can range from 0 -10. Higher 
scores indicate a stronger belief that: MD has many symptoms (identity), it will be chronic as 
opposed to acute (timeline acute/chronic), it has many consequences (consequences), it can 
be controlled by ones behavior (personal control) or by treatment (treatment control), it is 
understandable (illness coherence), it is an emotive (emotional representation) or concerning 
experience (concern). These domains are summed to give a total score, which quantifies the 
extent to which the illness is viewed as threatening (Broadbent et al., 2006). The internal 
consistency for the combined score of the Brief IPQ was very poor. Thus exploratory factor 
 PSYCHOLOGICAL FLEXIBILITY IN MUSCLE DISORDERS     9 
 
analyses were undertaken using principal components analysis (varimax rotation). The 
number of factors extracted was based on Kaiser’s criterion (Kaiser, 1960) and inspection of 
the scree plot (Field, 2013). This yielded three latent variables; however, only one showed 
acceptable internal and conceptual consistency (α = .71). This variable comprised the 
consequences, identity, emotional representation and concern domains; thus, it appears to 
capture the level of threat represented by MD - henceforth called IPQ Threat. 
The Cognitive Fusion Questionnaire (CFQ) (Gillanders et al., 2014) recorded 
cognitive fusion: “the tendency for behaviour to be overly regulated and influenced by 
cognition, compared to other sources of behavioral influence” (Gillanders et al., 2014). With 
seven items, scores range from 7-49. Higher scores indicate more cognitive fusion. Means for 
multiple sclerosis and community samples are 22.22 (10.36) and  22.28 (8.30) respectively 
(Gillanders et al., 2014).  Internal consistency in the present study was excellent (α = .95).  
The Acceptance and Action Questionnaire (AAQ)(Hayes et al., 2004) recorded 
experiential avoidance: a regulatory strategy comprising attempts to control or avoid 
unpleasant thoughts, feelings/or and bodily sensations (Machell, Goodman, & Kashdan, 
2014). The AAQ consists of nine items. Scores can range from 9-63; higher scores indicating 
greater experiential avoidance. The internal consistency was acceptable (α = .73).  The 
average score in non-mental health populations is between 32-37 (Hayes et al., 2004). 
The Engaged Living Scale (ELS) (Trompetter et al., 2013) is a 16 item measure of 
the ACT conceptualization of valued-living. Scores range from 16-80, and higher scores 
indicate greater valued-living. In a non-clinical sample the mean of the ELS is 60.80 (7.83), 
in those with chronic pain it is 50.90 (9.81) (Trompetter et al., 2013). Excellent internal 
consistency was apparent (α = .94). 
Data Analyses Plan and Statistics. 
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Multiple hierarchical regression analyses (enter method), conducted using SPSS 
version 21 (IBM, Released 2012), comprised the cross-sectional and prospective regression 
analyses. The cross-sectional regression analyses simply assessed the additive ability of 
independent variables to explain variance in each dependent variable at time 1. In the 
prospective analyses, the dependent variable was change in variance in the dependent 
variables over four months. This involved controlling for variance in the dependent variable 
measured at time 1. Thus, it can be inferred that variance in the T1 independent variable is 
antecedent to change in the dependent variable to T2 (Dalecki & Willits, 1991). In the 
analyses, independent variables were entered in the following steps: disability level (HAQ-
DI), followed by illness perceptions (Brief IPQ), then facets of psychological flexibility 
(valued-living [ELS]; cognitive fusion [CFQ]; experiential avoidance [AAQ]).  The time 1 
dependent variable was entered as a preliminary first step in the prospective regressions.  
Results 
Description of Cohort 
At time 1, 191 participants completed all items. Of this group, 137 (71.72%) 
completed the second questionnaire battery. The main MD diagnoses groups were: limb-
girdle muscular dystrophy (N=42); facioscapulohumeral muscular dystrophy (N = 28); 
inclusion body myositis (N =20); Becker muscular dystrophy (N =13) polymyositis and 
dermatomyositis (N = 7). The remainder (N =27) had a range of MDs, including: 
oculopharyngeal muscular dystrophy and Emery-Dreifuss muscular dystrophy. The average 
age was 46.74 years (SD = 13.56); average years with MD was 23.19 years (SD = 14.00). 
More females (N = 80) than males (N=57) participated. Mann-Whitney U Tests and chi-
square tests, corrected for multiple comparisons, revealed no significant differences between 
those who completed both questionnaires batteries and those who completed just battery one. 
Preliminary Data Analyses 
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Paired t-tests and Wilcoxon tests showed that, over 4 months, life satisfaction 
worsened (T1 Mean: 18.54 [SD = 7.79], T2 Mean: 17.01 [SD = 7.52] t[136] = 3.23; p < .01) 
but no significant changes in anxiety (Z = -.36, p = .72), or depression (Z = -.17, p = .86) 
were observed (Table 1). Disability level increased slightly over this time-period (Z = -2.38, p 
= .02), (Median [SE] T1 = 2.13 [0.72], Mean [SD] T1 = 2.02[0.78]; Median [SE] T2 = 2.13 
[0.60], Mean [SD] T2 = 2.08 [0.72]). Mean PF score appeared to be no higher than would be 
expected in a normal population, and PF was independent from disability level (Table 1). 
Regression Analyses 
The assumptions for regression were met, with some exceptions; HAQ-DI, CFQ, 
GAD 7 and PHQ-9 variables were skewed. These were transformed, which resulted in 
marked improved normality for just the CFQ and HAQ-DI. Thus, where GAD-7 and PHQ-9 
were the dependent variables, robust regression procedures were employed (Field, 2013).  
In the cross-sectional analyses illness perceptions explained significant proportions of 
variance (ΔR2 = 0.26-0.27, p <.001). However, PF (ΔR2 = 0.17-0.43, p <.001) explained 
significant additional proportions of variance in all dependent variables (Supplementary 
Tables 1-3). In the prospective analyses which controlled for time 1 variance in the dependent 
variable (i.e. where change over four months in the each respective outcome became the 
dependent variable) (Tables 2-4), most of the variance in each time 2 dependent variable was 
explained by the respective time 1 dependent variable (ΔR2 = 0.52-0.68, p <.001). 
Nonetheless, PF explained small but significant proportions of additional variance in life 
satisfaction (ΔR2 = 0.04, p = .01) and anxiety (ΔR2 = 0.03 p = .04). Experiential avoidance (β 
= -0.22, p = .01) was negatively associated with life satisfaction; while cognitive fusion (β = 
0.22, p =.01) was positively associated with this outcome. No one facet of PF was a 
significant predictor of anxiety, rather a combination of the included variables predicted a 
significant proportion of variance. Illness perceptions were not predictive of variance in any 
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of these regressions (ΔR2 = 0.00-0.01, p = .17-.99) and no independent variables were 
predictive of changes in depression over time. Disability level did not explain a significant 
proportion of variance in any dependent variable (ΔR2 = 0.00-0.01, p =.14-.86). 
Discussion 
We investigated the cross-sectional and prospective influence of PF on life 
satisfaction and mood, after demographics, disability and illness perceptions were included in 
the analyses. As in previous studies (Graham et al., 2014; Rose et al., 2012; Sadjadi et al., 
2010), in cross-sectional analyses illness perceptions explained large proportions of variance. 
Encouragingly, PF explained significant additional proportions of variance in each dependent 
variable. This suggests that PF makes a distinct contribution to explaining important 
outcomes in MDs - over, and above, a psychological variable with proven explanatory value 
(illness perceptions).  
Since the direction of influence could not be ascertained from these cross-sectional 
analyses, and it is feasible that life satisfaction and mood may influence PF, prospective 
analyses were then undertaken. Baseline levels of each dependent variable explained large 
proportions of the variance in outcome variables (life satisfaction, anxiety and depression) 
over four months (52%-68% of the variance). This left little remaining free variance, making 
this a particularly tough test for the independent variables. Nonetheless, PF predicted small 
but significant additional proportions of variance in both change in life satisfaction and 
anxiety over four months. This is important because it suggests that PF is more than just an 
epi-phenomenon to change in these dependent variables, but rather it may influence their 
change over time. Interestingly, illness perceptions were not predictive of change over time. 
The clinical implication is that PF represents a meaningful treatment target that can influence 
outcomes, even in the face of high disability levels. Subsequent research should thus 
experimentally manipulate PF, perhaps in a trial of ACT, to establish if this leads to improved 
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outcomes. Similar intervention studies have returned encouraging results in other chronic 
diseases (Feros, Lane, Ciarrochi, & Blackledge, 2013; Gregg, Callaghan, Hayes, & Glenn-
Lawson, 2007; Hawkes et al., 2013).  
No independent variables predicted significant proportions of variance in change in 
depression over four months. This result is most plausibly explained by the lack of remaining 
free variance in the dependent variable, after time 1 depression had previously explained 
particularly large proportions of variance (68%).  
Intriguing relationships between facets of PF and later outcomes were observed in the 
prospective analyses. In agreement with a study of pain in MDs (Kratz et al., 2013), later life 
satisfaction was negatively associated with experiential avoidance. Yet, surprisingly life 
satisfaction was also positively related to cognitive fusion. Cumulatively this suggests that 
life satisfaction benefits from a) viewing thoughts as real and literal (cognitive fusion), while 
b) being open to experiencing unpleasant private events, such as difficult thoughts and 
feelings (experiential acceptance). This combination of high cognitive fusion and low 
experiential avoidance may align with an attitude of ‘stoic’ acceptance – in other words, of 
‘just getting on with it’ - which showed positive associations with quality of life in an earlier 
study with MDs (Ahlstrom & Sjoden, 1996). Another explanation is: since cognitive fusion 
regards thought process and not thought content, alongside having experiential acceptance, 
individuals with good outcomes hold salient positive thoughts which they see as factual. 
In the present study, PF predicted significant proportions of variance in later anxiety. 
This adds to the literature which suggests that PF influences anxiety across populations 
(Masuda & Tully, 2012; McCracken, Gutiérrez-Martínez, & Smyth, 2013; White et al., 
2013). However, no one facet of PF was significantly predictive of anxiety; rather it was the 
combination of all PF variables. Larger sample sizes may be required to tease out the 
individual relationships between these facets and outcomes.  
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Limitations and suggestions for future research 
This study also used an observational design, thus experimental designs which 
manipulate independent variables are required to make stronger claims regarding causality.  
The demographic composition was very similar (age, years with MD, proportion of different 
MDs) to an earlier sample drawn from UK National Health Service clinics (Graham et al., 
2014). Nonetheless, the exclusion criteria, which were used to help minimize the risk of 
someone without capacity to consent participating (e.g. cognitive impairment, severe 
psychiatric diagnoses), may limit the representativeness of the sample compared to a clinical 
sample. Indeed, our assumed self-awareness of psychiatric diagnosis may have been 
problematic because some participants may have been diagnosed with conditions that they do 
not remember or recognise (Marrie et al., 2009). Also, due to the somatic focus of some items 
on the mood questionnaires, conflation of MD symptoms with mood may have caused an 
overestimation of mood disturbance. 
As half of the domains from the Brief IPQ were not used and only one measure of 
illness perceptions was included, compared to three measures of PF, direct comparison 
between the performances of these constructs is discouraged. Finally, given that  PF includes 
processes implicit in other therapeutic modalities, such as mindfulness-based approaches 
(Pagnini, Phillips, Bosma, Reece, & Langer, 2015), the results infer that investigation of 
mindfulness processes may also be warranted.    
Conclusion 
PF explains unique variance in life satisfaction, depression and anxiety, and predicts 
change in life satisfaction and anxiety over four months. This suggests that PF is an 
influential process in MDs. Experimental studies are required to establish if manipulation of 
PF leads to improved outcomes.   
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Table & Figures 
Table 1. Means (standard deviations) and inter-correlations (Pearson’s r) between key study 
variablesa 
  
M (SD) 
 
1. 
 
2. 
 
3. 
 
4. 
 
5. 
 
6. 
 
7. 
 
8. 
 
9. 
 
10. 
 
11. 
1. SWLS T1 18.54 
(7.79) 
 -.49** -.52** -.11  -52** -.57**  .38**  .74** .72** -.43** -.40** 
2. GAD-7 T1 4.31       
(4.4) 
   .79**   .02  .50**  .53**    .60**  - .56** -.38** .75** .67** 
3. PHQ-9 T1 6.58  
(5.36) 
   .08   53** .53** .50** -.56** -.50** .65** .83** 
4. HAQ-DI 
T1 
2.02  
(0.78) 
      .23*   .01   .06   .03 -.10 -.07 .06 
5. IPQ 
Threat T1 
26.73 
(7.66) 
     .53** .46** -.44** -.44** .40** .43** 
6. AAQ T1 32.88 
(8.90) 
      .58** -.66** -.51** .50** .48** 
7. CFQ T1 19.96 
(9.56) 
       -.53** -.23** .52** .43** 
8. ELS T1 54.50 
(13.37) 
        .56** .55** -.45** 
9. SWLS T2 17.01 
(7.52) 
         -.34** -.44** 
10. GAD-7 
T2 
4.23  
(4.28) 
          .68** 
11. PHQ-9 
T2 
6.48  
(5.36) 
           
*Significant association at less than or equal to p =.05. 
**Significant association at less than or equal to p=.01. 
aWhere appropriate, transformed variables were used; presented means (SD) are for untransformed variables. 
AAQ = Acceptance and Action Questionnaire (experiential avoidance); CFQ = Cognitive Fusion Questionnaire (cognitive 
fusion); ELS = Engaged Living Scale (valued-living); GAD-7 = Generalized Anxiety Disorder 7 item Scale (anxiety); HAQ-
DI = Health Assessment Questionnaire – Disability Index (disability level); IPQ Threat = Brief Illness Perception 
Questionnaire Threat Scale (illness perceptions); PHQ-9 = Patient Health Questionnaire 9 item Scale (depression); SWLS= 
Satisfaction with Life Scale (life satisfaction)  
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Table  2. Prospective hierarchical regression analyses showing the influence of baseline 
independent variables on change in life satisfaction (SWLS) over four months. 
 
  
Step Variable β t p R2 ΔR2 
 
ΔF 
p 
1 T1 Life Satisfaction (SWLS) .72 12.14 <.001 .52 .52 147.31 <.001 
2 T1 Life Satisfaction (SWLS) .72 11.99 <.001 .52 .00 0.72 .789 
 Disability Level (HAQ-DI) -.02 -.27 .79     
3 T1 Life Satisfaction (SWLS .67 9.61 <.001 .52 .01 1.95 .165 
 Disability Level (HAQ-DI) .00 0.02 .99     
 Illness Threat 
(IPQ-Threat) 
-.10 -1.40 .17     
4 T1 Life Satisfaction (SWLS) .59 6.33 <.001 .56 .04 3.65 .014 
 Disability Level (HAQ-DI) -.02 -0.30 .77     
 Illness Threat 
(IPQ-Threat) 
-.10 -1.32 .19     
 Experiential Avoidance (AAQ) -.22 -2.55 .01     
 Cognitive Fusion (CFQ) .22 2.78 .01     
 Valued-living (ELS) .06 0.58 .57     
         
Method: Enter 
 
SWLS= Satisfaction with Life Scale; HAQ-DI = Health Assessment Questionnaire – 
Disability Index; IPQ Threat = Brief Illness Perception Questionnaire Threat Scale; AAQ = 
Acceptance and Action Questionnaire; CFQ = Cognitive Fusion Questionnaire; ELS = 
Engaged Living Scale. 
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Table 3. Prospective hierarchical regression analyses showing the influence of baseline 
independent variables on change in anxiety (GAD 7) over four months†  
 
  
Step Variable β t p R2 ΔR2 
 
ΔF 
p 
1 T1 Anxiety (GAD-7) .75 12.96 <.001 .56 .56 168.07 <.001 
2 T1 Anxiety (GAD-7) .75 13.05 <.001 .56 .01 2.20 .14 
 Disability Level (HAQ-DI) -.09 -1.48 .17     
3 T1 Anxiety (GAD-7) .71 10.75 <.001 .57 .00 1.00 .32 
 Disability Level (HAQ-DI) -.10 -1.69 .11     
 Illness Threat 
(IPQ-Threat) 
.07 1.00 .31     
4 T1 Anxiety (GAD-7) .59 7.58 <.001 .59 .03 2.78 .04 
 Disability Level (HAQ-DI) -.08 -1.42 .17     
 Illness Threat 
(IPQ-Threat) 
.00 -0.01 .99     
 Experiential Avoidance (AAQ) .05 -0.53 .67     
 Cognitive Fusion (CFQ) .08 1.03 .35     
 Valued-living (ELS) -.14 -1.68 .11     
         
Method: Enter 
 
GAD-7= General Health Questionnaire 7 item version; HAQ-DI = Health Assessment 
Questionnaire – Disability Index; IPQ Threat = Brief Illness Perception Questionnaire Threat 
Scale; AAQ = Acceptance and Action Questionnaire; CFQ = Cognitive Fusion 
Questionnaire; ELS = Engaged Living Scale. 
 
† Bootstrapped p-values reported 
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Table 4. Prospective hierarchical regression analyses showing the influence of baseline 
independent variables on change in depression (PHQ 9) over four months†. 
 
  
Step Variable β t p R2 ΔR2 
 
ΔF 
p 
1 T1 Depression (PHQ-9) .83 17.06 <.001 .68 .68 291.06 <.001 
2 T1 Depression (PHQ-9) .83 16.95 <.001 .68 .00 0.03 .86 
 Disability Level (HAQ-DI) -.01 -0.17 .88     
3 T1 Depression (PHQ-9) .83 14.39 <.001 .68 .00 0.00 .99 
 Disability Level (HAQ-DI) -.01 -0.17 .87     
 Illness Threat 
(IPQ-Threat) 
.00 0.00 .99     
4 T1 Depression (PHQ-9) .82 12.56 <.001 .69 .01 0.84 .47 
 Disability Level (HAQ-DI) -.01 -0.11 .91     
 Illness Threat 
(IPQ-Threat) 
-.02 -0.36 .70     
 Experiential Avoidance (AAQ) .11 -1.50 .12     
 Cognitive Fusion (CFQ) -.01 -0.07 .96     
 Valued-living (ELS) .07 1.01 .37     
         
Method: Enter 
PHQ-9= Patient Health Questionnaire 9-item version; HAQ-DI = Health Assessment 
Questionnaire – Disability Index; IPQ Threat = Brief Illness Perception Questionnaire Threat 
Scale; AAQ = Acceptance and Action Questionnaire; CFQ = Cognitive Fusion 
Questionnaire; ELS = Engaged Living Scale. 
 
† Bootstrapped p-values reported 
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Supplementary Table 1. Cross-sectional hierarchical regression analyses showing the 
contribution of baseline independent variables to baseline depression (PHQ 9). 
 
  
Step Variable β t p R2 ΔR2 
 
ΔF 
p 
1 Disability Level (HAQ-DI) -.11 -1.29 .20 .01 .01 1.68 .20 
2 Disability Level (HAQ-DI) .01 0.11 .92 .27 .26 47.92 <.001 
 Illness Threat 
(IPQ-Threat) 
-.52 -6.92 <.001     
3 Disability Level (HAQ-DI) -.08 -1.47 .14 .62 .34 39.22 <.001 
 Illness Threat 
(IPQ-Threat) 
-.22 -3.27 .001     
 Experiential Avoidance (AAQ) -.10 -1.22 .23     
 Cognitive Fusion (CFQ) .13 1.81 .07     
 Valued-living (ELS) .66 8.75 <.001     
         
Method: Enter 
PHQ-9= Patient Health Questionnaire 9-item version; HAQ-DI = Health Assessment 
Questionnaire – Disability Index; IPQ Threat = Brief Illness Perception Questionnaire Threat 
Scale; AAQ = Acceptance and Action Questionnaire; CFQ = Cognitive Fusion 
Questionnaire; ELS = Engaged Living Scale. 
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Supplementary Table 2. Cross-sectional hierarchical regression analyses showing the 
contribution of baseline independent variables to baseline anxiety (PHQ 9) †. 
 
  
Step Variable β t p R2 ΔR2 
 
ΔF 
p 
1 Disability Level (HAQ-DI) .02 0.25 .80 -.01 .00 0.06 .801 
2 Disability Level (HAQ-DI) -.10 -1.26 .25 .25 .26 46.18 <.001 
 Illness Threat 
(IPQ-Threat) 
.52 6.80 <.001     
3 Disability Level (HAQ-DI) -.04 -0.59 .60 .47 .23 19.75 <.001 
 Illness Threat 
(IPQ-Threat) 
.20 -2.58 .02     
 Experiential Avoidance (AAQ) .03 -0.35 .69     
 Cognitive Fusion (CFQ) .38 4.50 <.001     
 Valued-living (ELS) -.23 -2.67 .016     
         
Method: Enter 
PHQ-9= Patient Health Questionnaire 9-item version; HAQ-DI = Health Assessment 
Questionnaire – Disability Index; IPQ Threat = Brief Illness Perception Questionnaire Threat 
Scale; AAQ = Acceptance and Action Questionnaire; CFQ = Cognitive Fusion 
Questionnaire; ELS = Engaged Living Scale. 
† Bootstrapped p-values reported 
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Supplementary Table 3. Cross-sectional hierarchical regression analyses showing the 
contribution of baseline independent variables to baseline depression (PHQ 9) †. 
 
  
Step Variable β t p R2 ΔR2 
 
ΔF 
p 
1 Disability Level (HAQ-DI) .08 0.97 .33 .01 .01 0.95 .332 
2 Disability Level (HAQ-DI) -.04 -0.50 .61 .28 .27 50.53 <.001 
 Illness Threat 
(IPQ-Threat) 
.54 7.11 <.001     
3 Disability Level (HAQ-DI) .02 0.31 .77 .45 .17 13.06 <.001 
 Illness Threat 
(IPQ-Threat) 
.26 3.16 .02     
 Experiential Avoidance (AAQ) .08 0.87 .34     
 Cognitive Fusion (CFQ) .20 2.22 .09     
 Valued-living (ELS) -.28 -3.10 <.01     
         
         
Method: Enter 
PHQ-9= Patient Health Questionnaire 9-item version; HAQ-DI = Health Assessment 
Questionnaire – Disability Index; IPQ Threat = Brief Illness Perception Questionnaire Threat 
Scale; AAQ = Acceptance and Action Questionnaire; CFQ = Cognitive Fusion 
Questionnaire; ELS = Engaged Living Scale. 
† Bootstrapped p-values reported 
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